TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Takeda Pharma A/S
Closing information (x1000 EUR)
Closing information | 2022/03 | 2021/03 | 2020/03 |
Turnover | 122,354 | 260,744 | 210,165 |
Earnings before taxes | 5,744 | 122,857 | 443,374 |
Total assets | 83,665 | 271,203 | 509,134 |
Current assets | 74,829 | 262,338 | 492,358 |
Current liabilities | 70,665 | 128,069 | 142,181 |
Equity capital | 10,922 | 140,696 | 362,493 |
- share capital | 1,358 | 1,358 | 1,352 |
Employees (average) | 350 | 350 | 350 |
Financial ratios
Fiscal year | 2022/03 | 2021/03 | 2020/03 |
Solvency | 13.1% | 51.9% | 71.2% |
Turnover per employee | 350 | 745 | 600 |
Profit as a percentage of turnover | 4.7% | 47.1% | 211.0% |
Return on assets (ROA) | |||
Current ratio | 105.9% | 204.8% | 346.3% |
Return on equity (ROE) | 52.6% | 87.3% | 122.3% |
Change turnover | -138,369 | 49,701 | -225 |
Change turnover % | -53% | 24% | 0% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/03 | 2021/03 | 2020/03 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.